je.st
news
J&J leukemia drug cuts death risk vs. chemo in new patients: study
2015-12-07 03:47:40| Food - Topix.net
Johnson & Johnson's and AbbVie's cancer drug Imbruvica significantly reduced the risk of death and disease progression compared with chemotherapy in previously untreated patients with a type of leukemia in a late stage study, paving the way for an expanded approval of the medicine. In the trial of 269 patients aged 65 and older with chronic lymphocytic leukemia , Imbruvica decreased risk of death by a statistically significant 85 percent compared with the chemotherapy chlorambucil, researchers reported on Sunday.
Tags: study
death
risk
drug
Category:Food and Related Products
Latest from this category |
All news |
||
|
|||